Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

NCT00016549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Bevacizumab

Sponsor

National Cancer Institute (NCI)